Clinical Trial Update: A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating the safety and efficacy of MEDI0618 versus placebo for episodic migraine in adults; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• MEDI0618

Snippet

Sponsor: AbbVie | Conditions: Migraine | Phase 2 | Status: RECRUITING